Drug Approval | January 28, 2022
European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
The covid health center will be managed and administered by the district administration of Ballari
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The company has been manufacturing masks since the Covid-19 outbreak in 2020
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Subscribe To Our Newsletter & Stay Updated
